Corey Langer, MD, provides a general introduction to lung cancer, explaining the current issues confronting clinicians and investigators, including the continuing late diagnosis of the disease and underfunding of research, as well as the promise at Penn Medicine and elsewhere of new technologies (e.g., protons, SBRT, genetic profiling) molecular therapies and immunotherapy in the treatment of lung cancer at all stages.
Related Links:
Remote Access Genetic Counseling for Patients in the Community Setting
Dr Langer’s Profile
Published
February 13, 2018
Created by
BROADCASTMED